Repression of the TMEFF2 Promoter by c-Myc

Journal of Molecular Biology

Volumn 328, Issue 5, 2003, Pages 977-983

  Gery, Sigal ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

c Myc; Growth inhibition; Promoter; TMEFF2; Transcriptional suppression

Indexed keywords

LUCIFERASE; PROTEIN; PROTEIN TMEFF2; TOMOREGULIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; DNA FLANKING REGION; ELECTROPHORETIC MOBILITY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MALE; MOLECULAR BIOLOGY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION SITE; XENOGRAFT;

EID: 0037449140     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00404-2     Document Type: Article

References (26)

1. Glynne-Jones E., Harper M.E., Seery L.T., James R., Anglin I., Morgan H.E., et al. TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int. J. Cancer. 94:2001;178-184.
2. Horie M., Mitsumoto Y., Kyushiki H., Kanemoto N., Watanabe A., Taniguchi Y., et al. Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons. Genomics. 67:2000;146-152.
3. Liang G., Robertson K.D., Talmadge C., Sumegi J., Jones P.A. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Cancer Res. 60:2000;4907-4912.
4. Uchida T., Wada K., Akamatsu T., Yonezawa M., Noguchi H., Mizoguchi A., et al. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem. Biophys. Res. Commun. 266:1999;593-602.
5. Young J., Biden K.G., Simms L.A., Huggard P., Karamatic R., Eyre H.J., et al. HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc. Natl Acad. Sci. USA. 98:2001;265-270.
6. Gery S., Sawyers C.L., Agus D.B., Said J.W., Koeffler H.P. TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells. Oncogene. 21:2002;4739-4746.
7. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:2000;653-699.
8. Dang C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell Biol. 19:1999;1-11.
9. Wagner A.J., Meyers C., Laimins L.A., Hay N. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:1993;879-883.
10. Galaktionov K., Chen X., Beach D. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature. 382:1996;511-517.
11. Claassen G.F., Hann S.R. Myc-mediated transformation: the repression connection. Oncogene. 18:1999;2925-2933.
12. Eisenman R.N. Deconstructing myc. Genes Dev. 15:2001;2023-2030.
13. Marhin W.W., Chen S., Facchini L.M., Fornace A.J. Jr, Penn L.Z. Myc represses the growth arrest gene gadd45. Oncogene. 14:1997;2825-2834.
14. Lee T.C., Li L., Philipson L., Ziff E.B. Myc represses transcription of the growth arrest gene gas1. Proc. Natl Acad. Sci. USA. 94:1997;12886-12891.
15. (WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc. Natl Acad. Sci. USA. 98:2001;4510-4515.
16. Staller P., Peukert K., Kiermaier A., Seoane J., Lukas J., Karsunky H., et al. Repression of p15INK4b expression by Myc through association with Miz-1. Nature Cell Biol. 3:2001;392-399.
17. Yang W., Shen J., Wu M., Arsura M., FitzGerald M., Suldan Z., Kim D.W., et al. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene. 20:2001;1688-1702.
18. Smale S.T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
19. Li L.H., Nerlov C., Prendergast G., MacGregor D., Ziff E.B. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13:1994;4070-4079.
20. Roy A.L., Carruthers C., Gutjahr T., Roeder R.G. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature. 365:1993;359-361.
21. Engler D.A., Montelione G.T., Niyogi S.K. Human epidermal growth factor. Distinct roles of tyrosine 37 and arginine 41 in receptor binding as determined by site-directed mutagenesis and nuclear magnetic resonance spectroscopy. FEBS Letters. 271:1990;47-50.
22. Kupprion C., Motamed K., Sage E.H. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem. 273:1998;29635-29640.
23. Patel K. Follistatin. Int. J. Biochem. Cell Biol. 30:1998;1087-1093.
24. Patthy L., Nikolics K. Functions of agrin and agrin-related proteins. Trends Neurosci. 16:1993;76-81.
25. Agus D.B., Cordon-Cardo C., Fox W., Drobnjak M., Koff A., Golde D.W., Scher H.I. Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence. J. Natl Cancer Inst. 91:1999;1869-1876.
26. Stone J., de Lange T., Ramsay G., Jakobovits E., Bishop J.M., Varmus H., Lee W. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell Biol. 7:1987;1617-1697.